Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$72.34 - $84.0 $2.19 Million - $2.54 Million
-30,250 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$62.63 - $80.22 $1.89 Million - $2.43 Million
30,250 New
30,250 $2.26 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Barometer Capital Management Inc. Portfolio

Follow Barometer Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barometer Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Barometer Capital Management Inc. with notifications on news.